How progestins influence the cardiovascular effect of hormone replacement therapy

REFERENCES

• Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979;54:74–9
   Google Scholar
• Falkeborn M, Persson I, Adami HO, et al. The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement. BrJ Obstet Gynaecol 1992;99:821–8
   PubMedGoogle Scholar
• Psaty BM, Heckberr SR, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in post-menopausal women. Arch Intern Med 1994;154:1333–9
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment o f the epidemiologic evidence. Prey Med 1991;20:47–63
   PubMed Web of Science ®Google Scholar
• Tikkanen MJ. Postmenopausal hormone replace-ment therapy: effects of progestogens on serum lipids and lipoproteins. A review. Maturitas 1986;8: 7–17
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replace-ment Study (HERS) Research Group. J Am Med Assoc 1998;280:605–13
   Web of Science ®Google Scholar
• Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994;266:E914–20
   Google Scholar
• Campos H, Sacks FM, Walsh BW, et al. Differen-tial effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1933;42:1153–8
   Google Scholar
• Rosano GMC, Panina G. Oestrogens and the heart. Therapie 1999;54:381–5
   PubMed Web of Science ®Google Scholar
• Krauss RM. Effects of progestational agents on serum lipids and lipoproteins. J Reprod Med 1982; 27:503–10
   PubMed Web of Science ®Google Scholar
• Rijpkema AHM, van den Sanden AA, Ruijs AHC. Effects of postmenopausal oestrogen-progesto gen replacement therapy on serum lipids and lipo-proteins: a review. Maturitas 1990;12:259–85
   PubMed Web of Science ®Google Scholar
• Jarrett RJ, Graver HJ. Changes in oral glucose turnover during the menstrual cycle. Br Med J 1968;2:528–9
   PubMedGoogle Scholar
• The Postmenopausal Estrogen/Progestin Inter-ventions Trial Writing Group. Effect o f estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women.J Am Med Assoc 1995;273:199–208
   Google Scholar
• Rosano GMC, Sarais C, Zoncu S, Mercuro G. The relative effects of progesterone and progestins in hormone replacement therapy. Hum Reprod 2000;15(Suppl 1):60–73
   PubMedGoogle Scholar
• FUnggi W, Lippuner K, Riensen W, Jaeger P, Birkhauser MH. Long term influence of different postmenopausal hormone replacement regimes on serum lipids and lipoprotein(a): a randomized study. Br J Obstet Gynaecol 1997;104:708–17
   Google Scholar
• Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the con-centrations and metabolism of plasma lipoproteins. N Eng1J Med 1991;325:1196–204
   PubMed Web of Science ®Google Scholar
• Godsland IF, Gangar KF, Walton C, et al. Insulin resistance, secretion, and elimination in post-menopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993; 42:846–53
   PubMed Web of Science ®Google Scholar
• Sporrong T, Mattsson LA, Samsioe G, et al. Haemostatic changes during continuous oestradiol-progestogen treatment of postmeno-pausal women. Br J Obstet Gynaecol 1990;97: 939–44
   PubMedGoogle Scholar
• Notelowitz M, Johnston M, Smith S, Kitchens C. metabolic and hormonal effects of 25 mg and 50 mg 1713-estradiol implants in surgically meno-pausal women. Obstet Gynecol 1987;70:749–54
   PubMed Web of Science ®Google Scholar
• Godsland IF. The influence of female sex steroids on glucose metabolism and insulin action. J Intern Med 1996;240(5upp1738):1–60
   Google Scholar
• Fahraeus L. Metabolic consequences of postmeno-pausal estrogen and progestogen treatment. Acta Obstet Gynecol Scand 1985;172 (Suppl):19–21
   Google Scholar
• Gaspard UJ, Go tta1J, van den Brule FA. Postmeno-pausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 1995;21: 171–8
   Google Scholar
• Gebara OCE, Mittlemann MA, Sutherland P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952–8
   PubMed Web of Science ®Google Scholar
• Koh KK, Mincemoyer R, Bui MN, et al. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 1997;336: 683–90
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Netelombos C, et al. Postmenopausal oral 1713-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998;69: 876–82
   PubMed Web of Science ®Google Scholar
• Clarke R, Daly L, Robinson K, et al. Hyperhomo-cysteinemia: an independent risk factor for vascular disease. N Eng1J Med 1991;324: 1149–55
   Google Scholar
• Stampfer MG, Manilow MR, Willet WC, et al. A prospective study of plasma homocysteine and risk of myo cardial infarction in US physicians. JAm Med Assoc 1992;268:877–81
   PubMed Web of Science ®Google Scholar
• Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:104
   Web of Science ®Google Scholar
• van der Mooren MJ, Wouters MGAJ, Blom HJ, et al. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733–6
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Jacobs C, et al. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998;91:432–6
   PubMed Web of Science ®Google Scholar
• Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991;261: R1022–7
   PubMedGoogle Scholar
• Adams MR, Kaplan JR, Manuck SB, et al. Inhibi-tion of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Atherosclerosis 1990;10:1051–7
   Google Scholar
• Adams MR, Register TC, Wagner JD, Williams JK. Effects of estrogens and progestins on the pathogenesis of atherosclerosis in non-human primate. In Forte TM, ed. Hormonal, Metabolic and Cellular Influences on Cardiovascular Disease in Women. New York: Futura Publishing, 1997: 39–53
   Google Scholar
• Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Post-menopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954–63
   PubMed Web of Science ®Google Scholar
• Sullivan JM, van der Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary athero-sclerosis. Ann Intern Med 1988;108:358–63
   PubMed Web of Science ®Google Scholar
• O'Keefe JH, Kim SC, Hall RR, et al. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997;29:1–5
   PubMed Web of Science ®Google Scholar
• Herrington DM, Reboussin DM, Brosnihan KB. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522–9
   Google Scholar
• Teede HJ, Liang YL, Shiel LM, et al. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J Am Coll Cardiol 1999;34:131–7
   PubMed Web of Science ®Google Scholar
• Maseri A, Labbate A, Chierchia S, et al. Signifi-cance of spasm in the pathogenesis of ischemic heart disease. Am J Cardiol 1979;44:788–92
   PubMed Web of Science ®Google Scholar
• Magness RR, Rosenfeld CR. Local and systemic estradiol 1713: effects on uterine and systemic vasodilation. Am J Physiol 1989;256:E536–42
   PubMed Web of Science ®Google Scholar
• Killam AP, Rosenfeld CR, Battaglia FC, et al. Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol 1973;115: 1045–52
   PubMed Web of Science ®Google Scholar
• Volterrani M, Rosano GMC, Coats A, et al. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995;99: 119–22
   PubMed Web of Science ®Google Scholar
• Williams SP, Shackelford DP, Lams SG, Mustafa SJ. Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur J Pharmacol 1988;145:205–7
   PubMed Web of Science ®Google Scholar
• Gisclard V, Miller VM, Vanhoutte PM. Effect of 1713-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244: 19–22
   Google Scholar
• Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786–91
   PubMed Web of Science ®Google Scholar
• Rosano GMC, Leonardo F, Ponikowski P, et al. Estrogen replacement therapy normalizes the autonomic control of the cardiovascular system in menopausal women. J Am Coll Cardiol 1996;27:2 suppl A (abstr)
   Google Scholar
• Hamlet MA, Rorie DK, Tyce GM. Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 1980;239:H450–6
   Google Scholar
• van Ittersum FJ, van Baal WM, Kenemans P, et al. Ambulatory - not office - blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998;11: 1147–52
   PubMed Web of Science ®Google Scholar